Skip to the content

pharmaceutical daily

Pharmaceuticals, Biotechnology and Life Sciences

  • HOME
  • Pharma Business
  • About us
    • Media Kit
    • Privacy Policy
  • Contact
June 3, 2019 Off

Life Science Industry in California Generates $346 Billion Annually, Providing Nearly 1.3M Jobs

By BusinessWire

Biocom’s 2019 Economic Impact Report Highlights the Steady Growth of the Industry Throughout the State SAN DIEGO–(BUSINESS WIRE)–#BayArea—California’s life science…

June 3, 2019 Off

Rainier Therapeutics Announces Results from First Interim Analysis of the FIERCE-22 Trial of Vofatamab in Combination with Pembrolizumab in Patients with Metastatic Urothelial Cell Carcinoma (Bladder Cancer)

By BusinessWire

-Targeted antibody elicits responses in both FGFR3 wild-type and mutant/fusion patients- -Favorable tolerability and safety profile and prolonged treatment duration-…

June 3, 2019 Off

Aadi Bioscience Breakthrough Therapy nab-Sirolimus (ABI-009) Preliminary Data Released from the AMPECT Registration Trial in Advanced PEComa

By BusinessWire

Highlights: 42% investigator-assessed ORR achieved in patients with advanced PEComa – a rare sarcoma with no currently approved therapy First…

June 3, 2019 Off

Dr. Reddy’s Laboratories Announces the Re-Launch of Zenatane® (Isotretinoin Capsules, USP), 10 mg, 20 mg, 30 mg and 40 mg in the U.S. Market

By BusinessWire

HYDERABAD, India & PRINCETON, N.J.–(BUSINESS WIRE)–Dr. Reddy’s Laboratories Ltd. (BSE: 500124) (NSE: DRREDDY) (NYSE: RDY) (along with its subsidiaries together…

June 3, 2019 Off

Imbruvica®▼ (ibrutinib) Long-Term Data from Two Pivotal Phase 3 Studies at ASCO and EHA Demonstrate Sustained Efficacy and Safety in Patients with Chronic Lymphocytic Leukaemia (CLL)

By BusinessWire

With up to six years of follow-up, results from the RESONATETM study showed patients with previously treated CLL receiving ibrutinib…

June 3, 2019 Off

Cerevance Appoints CNS Drug Developer James Summers, Ph.D. as Scientific Advisor

By BusinessWire

Dr. Summers to help guide Cerevance’s Drug Discovery and Development Efforts BOSTON–(BUSINESS WIRE)–#CNS–Cerevance, a clinical stage biopharmaceutical company advancing new…

June 3, 2019 Off

KD Pharma Strengthens Its Technology Platform by Acquiring UK Manufacturing Site

By BusinessWire

Acquisition allows KD Pharma to further expand its leading position in the omega-3 pharmaceutical market BIOGGIO, Switzerland–(BUSINESS WIRE)–KD Pharma Group…

June 3, 2019 Off

InterVenn BioSciences Enrolls First Patients in VOCAL Trial

By BusinessWire

New ovarian cancer test combines AI and Mass Spec in an effort to better identify cancerous ovarian tumors from benign…

June 3, 2019 Off

bluebird bio Announces EU Conditional Marketing Authorization for ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent β-Thalassemia Who Do Not Have β0/β0 Genotype

By BusinessWire

ZYNTEGLO is the first gene therapy approved for transfusion-dependent β-thalassemia (TDT) European marketing authorization for ZYNTEGLO follows the fastest assessment…

June 3, 2019 Off

bluebird bio Announces EU Conditional Marketing Authorization for ZYNTEGLO™ (autologous CD34+ cells encoding βA-T87Q-globin gene) Gene Therapy for Patients 12 Years and Older with Transfusion-Dependent β-Thalassemia Who Do Not Have β0/β0 Genotype

By BusinessWire

ZYNTEGLO is the first gene therapy approved for transfusion-dependent β-thalassemia (TDT) European marketing authorization for ZYNTEGLO follows the fastest assessment…

Posts pagination

Previous 1 … 3,137 3,138 3,139 … 3,606 Next

JOIN OUR COMMUNITY

Proudly powered by WordPress | Theme: Envo Magazine